Autologous stem cell transplantation improves cardiopulmonary exercise testing outcomes in systemic sclerosis patients.
Leonardo Pippa GadioliKarla Costa-PereiraJuliana B E DiasDaniela A MoraesJúlio C CrescêncioPedro V SchwartzmannLourenço Gallo-JúniorAndré SchmidtMaria Carolina OliveiraPublished in: Rheumatology (Oxford, England) (2022)
AHSCT improves the aerobic capacity of SSc patients probably reflecting combined increments in lungs, skeletal muscle and cardiac function.
Keyphrases
- systemic sclerosis
- end stage renal disease
- stem cell transplantation
- skeletal muscle
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- high dose
- high intensity
- type diabetes
- physical activity
- interstitial lung disease
- bone marrow
- insulin resistance
- rheumatoid arthritis
- mesenchymal stem cells
- patient reported outcomes
- body composition